GO
Loading...

Amgen to buy Onyx for more than $10 billion

Monday, 26 Aug 2013 | 7:52 AM ET

Chris Raymond, Robert W. Baird analyst, discusses details of the fifth-biggest biotech deal in history, and the expanding field of biotech cancer drugs.